患者、肾内科医生及预测模型对ESKD风险的估计与2年实际发病率比较
这项前瞻性观察研究纳入257例CKD 3-5期患者及其肾内科医生,比较患者、医生和肾衰竭风险方程对2年ESKD风险的估计与实际结局。结果显示13%患者达到ESKD,9%死亡;医生与风险方程相关性最强(r=0.72),但医生和患者均高估风险,风险方程校准最佳。
要点
- 医生与肾衰竭风险方程对ESKD风险的估计相关性最强(r=0.72)。
- 医生和患者均高估ESKD风险,风险方程校准最佳。
- 医生估计ESKD风险<15%的患者2年内无一例达到ESKD。
核心结论
- 肾衰竭风险方程对ESKD发病率的预测优于患者和医生的估计。
- 患者和医生相比肾衰竭风险方程高估了ESKD风险。
研究设计与样本
- 前瞻性观察研究,纳入257例CKD 3-5期成人患者及其肾内科医生,来自加州大学圣地亚哥分校和退伍军人事务圣地亚哥CKD诊所。
- 评估患者和医生对2年ESKD风险的估计,使用肾衰竭风险方程计算客观风险,并通过病历回顾确定实际ESKD和死亡发生率。
主要发现
- 平均年龄65(±13)岁,eGFR 34(±13)ml/min per 1.73 m2。
- 总体13%达到ESKD,9%死亡。
- 约四分之一患者估计比医生乐观>20%,超过十分之一患者估计比医生悲观>20%。
- 医生与肾衰竭风险方程估计相关性r=0.72(P<0.001),医生与患者r=0.50(P<0.001),患者与方程r=0.47(P<0.001)。
- 所有三种估计均提供合理的风险排序(c统计量>0.8),但医生和患者高估风险;医生估计ESKD风险<15%的患者2年内无ESKD发生。
关键数值与推荐
- 肾衰竭风险方程对实际ESKD风险的校准最佳。
临床怎么用
- 临床中可使用肾衰竭风险方程客观评估ESKD风险,辅助患者和医生规划。
- 需注意患者和医生主观估计可能高估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The rate of progression to ESKD is variable, and prognostic information helps patients and physicians plan for future ESKD. We assessed the estimations of ESKD risk of patients with CKD and physicians and compared them with risk calculators and outcomes at 2 years. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This prospective observational study assessed 257 adult patients with CKD stages 3-5 and their nephrologists at University of California, San Diego and Veterans Affairs San Diego CKD clinics. Patients' and nephrologists' estimations of 2-year ESKD risk were evaluated, and objective estimation of 2-year risk was determined using kidney failure risk equations; actual incidence rates of ESKD and death were ascertained by chart review. Participants' baseline characteristics were compared across kidney failure risk equation risk levels and according to whether patients' estimations were more optimistic or pessimistic than physicians' estimations. We examined correlations between estimations and compared estimations with outcomes using c statistics and calibration plots. RESULTS: Average age was 65 (±13) years old, and eGFR was 34 (±13) ml/min per 1.73 m2. Overall, 13% reached ESKD, and 9% died. About one quarter of patients gave estimates that were >20% more optimistic than physicians, and more than one in ten gave estimates that were >20% more pessimistic. Physicians' and kidney failure risk equation estimations had the strongest correlation (r=0.72; P<0.001) compared with 0.50 (P<0.001) between physicians and patients and 0.47 (P<0.001) between patients and kidney failure risk equation. Although all three estimations provided reasonable risk rankings (c statistics >0.8), physicians and patients overestimated risk compared with actual outcomes; no patient whose physician estimated a risk of ESKD <15% reached ESKD at 2 years. The kidney failure risk equation was best calibrated to actual ESKD risk. CONCLUSIONS: Compared with actual ESKD incidence, the kidney failure risk equation outperformed patients' and physicians' estimations of ESKD incidence. Patients and physicians overestimated risk compared with the kidney failure risk equation.
引用
- Potok OA, Nguyen HA, Abdelmalek JA, et al. Patients,' Nephrologists,' and Predicted Estimations of ESKD Risk Compared with 2-Year Incidence of ESKD. Clin J Am Soc Nephrol. 2019. PMID: 30630859. doi:10.2215/CJN.07970718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。